SR

Suman Rabindra Kumar Shahi

Active Director Director DIN 07696641
DIN 07696641 First appointment Jan 2017 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Suman Rabindra Kumar Shahi

Data last updated:

Suman Rabindra Kumar Shahi is a Director at Rogant Pharmaceuticals Private Limited (since 2017). The company operates in Food And Beverages.

DIN 07696641
Primary Designation Director
Industry Food And Beverages
First Appointment 27 Jan 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jan 20172017Active

Board colleagues of Suman Rabindra Kumar Shahi

NameDINCompanyDesignation
Rabindra Kumar Shahi07696625Rogant Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rogant Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suman Rabindra Kumar Shahi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suman Rabindra Kumar Shahi

Suman Rabindra Kumar Shahi currently holds 1 directorship: Rogant Pharmaceuticals Private Limited (Director, since 27 Jan 2017).

Suman Rabindra Kumar Shahi was first appointed on 27 Jan 2017 as Director at Rogant Pharmaceuticals Private Limited.

The current boards of Suman Rabindra Kumar Shahi's companies include Rabindra Kumar Shahi (Rogant Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available